Katayama Yuta, Kyo Kouhei, Iwato Koji, Okatani Takeshi, Imanaka Ryota, Itagaki Mitsuhiro, Katsutani Shinya, Asaoku Hideki
Division of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital.
Division of Transfusion, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital.
Rinsho Ketsueki. 2017;58(11):2250-2255. doi: 10.11406/rinketsu.58.2250.
A 54-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) underwent hematopoietic stem cell transplantation from an HLA-matched sibling. Subsequently, she suffered from chronic graft versus host disease (GvHD) and received medical treatment. Fever developed on day 697 and resulted in a shock state at 10 h after the visit. Achromobacter xylosoxidans was detected in the initial blood culture on day 699. General conditions exacerbated even after the start of meropenem hydrate (MEPM, Meropen) administration, with Corynebacterium striatum detected as an additional species in the initial blood culture on day 701. Although vancomycin hydrochloride (VCM, Vancomycin) was administered, the conditions did not improve. She died on day 702. Between January 2012 and December 2016, A. xylosoxidans was detected only in nine cases in our hospital, which included five with hematological malignancies and only one (present) with sepsis. At the same time, Corynebacterium species were detected in blood cultures from 39 cases in our hospital, which included 31 with hematological malignancies. Some reports on drug-resistant A. xylosoxidans and C. striatum have been published. Infections with these species may become fatal when complicated by sepsis in immunocompromised patients with hematological malignancies. More cases should be accumulated for detailed investigation.
一名54岁的费城染色体阳性急性淋巴细胞白血病(Ph+ALL)女性患者接受了来自人类白细胞抗原(HLA)匹配同胞的造血干细胞移植。随后,她患上了慢性移植物抗宿主病(GvHD)并接受了治疗。在第697天出现发热,并在就诊后10小时导致休克状态。在第699天的初次血培养中检测到木糖氧化无色杆菌。即使在开始给予美罗培南水合物(MEPM,美平)后,一般状况仍恶化,在第701天的初次血培养中检测到纹带棒状杆菌作为另外一种病原菌。尽管给予了盐酸万古霉素(VCM,万古霉素),病情仍未改善。她于第702天死亡。在2012年1月至2016年12月期间,木糖氧化无色杆菌在我院仅在9例患者中被检测到,其中包括5例血液系统恶性肿瘤患者,只有1例(本病例)发生败血症。同时,我院从39例患者的血培养中检测到棒状杆菌属,其中包括31例血液系统恶性肿瘤患者。关于耐药木糖氧化无色杆菌和纹带棒状杆菌的一些报道已经发表。在血液系统恶性肿瘤免疫受损患者中,这些菌种感染并发败血症时可能会致命。需要积累更多病例进行详细研究。